Yu W, Wang C, Shang Z, Tian J
Front Oncol. 2023; 13:1224913.
PMID: 37746302
PMC: 10514910.
DOI: 10.3389/fonc.2023.1224913.
Hu W, Hu D, Xie L, Nonn L, Lu R, Abern M
Int J Mol Sci. 2021; 22(15).
PMID: 34360875
PMC: 8346986.
DOI: 10.3390/ijms22158109.
Catozzi S, Halasz M, Kiel C
NPJ Syst Biol Appl. 2021; 7(1):10.
PMID: 33580066
PMC: 7881153.
DOI: 10.1038/s41540-021-00170-0.
Jung Y, Kim J, Lee E, Cackowski F, Decker A, Krebsbach P
Prostate. 2020; 80(13):1145-1156.
PMID: 32659025
PMC: 7491592.
DOI: 10.1002/pros.24043.
Wang R, Chu G, Wang X, Wu J, Hu P, Multani A
Int J Cancer. 2019; 145(8):2249-2259.
PMID: 31020641
PMC: 6703920.
DOI: 10.1002/ijc.32370.
Role of Stromal Paracrine Signals in Proliferative Diseases of the Aging Human Prostate.
Ishii K, Takahashi S, Sugimura Y, Watanabe M
J Clin Med. 2018; 7(4).
PMID: 29614830
PMC: 5920442.
DOI: 10.3390/jcm7040068.
Prostate Organogenesis.
Francis J, Swain A
Cold Spring Harb Perspect Med. 2017; 8(7).
PMID: 29229667
PMC: 6027935.
DOI: 10.1101/cshperspect.a030353.
A basal cell defect promotes budding of prostatic intraepithelial neoplasia.
Wang M, Nagle R, Knudsen B, Rogers G, Cress A
J Cell Sci. 2016; 130(1):104-110.
PMID: 27609833
PMC: 5394777.
DOI: 10.1242/jcs.188177.
Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer.
Lefort K, Ostano P, Mello-Grand M, Calpini V, Scatolini M, Farsetti A
Oncotarget. 2016; 7(30):48011-48026.
PMID: 27384993
PMC: 5216996.
DOI: 10.18632/oncotarget.10333.
The many ways to make a luminal cell and a prostate cancer cell.
Strand D, Goldstein A
Endocr Relat Cancer. 2015; 22(6):T187-97.
PMID: 26307022
PMC: 4893788.
DOI: 10.1530/ERC-15-0195.
Novel In Vivo model for combinatorial fluorescence labeling in mouse prostate.
Fang X, Gyabaah K, Nickkholgh B, Cline J, Balaji K
Prostate. 2015; 75(9):988-1000.
PMID: 25753731
PMC: 4515139.
DOI: 10.1002/pros.22984.
Cytogenetic landscape of paired neurospheres and traditional monolayer cultures in pediatric malignant brain tumors.
Zhao X, Zhao Y, Lin Q, Yu L, Liu Z, Lindsay H
Neuro Oncol. 2014; 17(7):965-77.
PMID: 25537021
PMC: 5654349.
DOI: 10.1093/neuonc/nou337.
Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: emerging role and concepts.
Prajapati A, Gupta S, Mistry B, Gupta S
Biomed Res Int. 2013; 2013:107954.
PMID: 23936768
PMC: 3722776.
DOI: 10.1155/2013/107954.
β-catenin is required for prostate development and cooperates with Pten loss to drive invasive carcinoma.
Francis J, Thomsen M, Taketo M, Swain A
PLoS Genet. 2013; 9(1):e1003180.
PMID: 23300485
PMC: 3536663.
DOI: 10.1371/journal.pgen.1003180.
Polo-like kinase 1, on the rise from cell cycle regulation to prostate cancer development.
Luo J, Liu X
Protein Cell. 2012; 3(3):182-97.
PMID: 22447658
PMC: 4875424.
DOI: 10.1007/s13238-012-2020-y.
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.
Wu C, Wyatt A, Lapuk A, McPherson A, McConeghy B, Bell R
J Pathol. 2012; 227(1):53-61.
PMID: 22294438
PMC: 3768138.
DOI: 10.1002/path.3987.
Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis.
Nagle R, Cress A
Prostate Cancer. 2011; 2011:249290.
PMID: 21949592
PMC: 3177701.
DOI: 10.1155/2011/249290.
Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: autocrine effects on cell proliferation and migration.
Vo B, Khan S
Prostate. 2011; 71(10):1084-96.
PMID: 21557273
PMC: 3139718.
DOI: 10.1002/pros.21326.
Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies.
Ben Jemaa A, Bouraoui Y, Sallami S, Banasr A, Ben Rais N, Ouertani L
J Exp Clin Cancer Res. 2010; 29:171.
PMID: 21189143
PMC: 3023682.
DOI: 10.1186/1756-9966-29-171.
Molecular genetics of prostate cancer: new prospects for old challenges.
Shen M, Abate-Shen C
Genes Dev. 2010; 24(18):1967-2000.
PMID: 20844012
PMC: 2939361.
DOI: 10.1101/gad.1965810.